DnB Asset Management
SRPT icon

DnB Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

DnB Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,048
Closed -$577K – 768
2025
Q1 		$577K Buy
9,048
+2,361
+35% +$249K ﹤0.01% 647
2024
Q4 		$813K Sell
6,687
-3,719
-36% -$456K ﹤0.01% 642
2024
Q3 		$1.3M Buy
10,406
+5,212
+100% +$721K 0.01% 620
2024
Q2 		$820K Sell
5,194
-347
-6% -$44.6K ﹤0.01% 634
2024
Q1 		$717K Buy
+5,541
New +$679K ﹤0.01% 639
2021
Q4 		– Sell
-27,293
Closed -$2.52M – 683
2021
Q3 		$2.52M Buy
+27,293
New +$2.1M 0.02% 495
2021
Q2 		– Sell
-38,014
Closed -$2.83M – 650
2021
Q1 		$2.83M Buy
38,014
+7,085
+23% +$654K 0.02% 466
2020
Q4 		$5.27M Buy
30,929
+18,422
+147% +$2.73M 0.05% 256
2020
Q3 		$1.76M Sell
12,507
-899
-7% -$137K 0.02% 422
2020
Q2 		$2.15M Buy
13,406
+2,758
+26% +$375K 0.03% 366
2020
Q1 		$1.04M Sell
10,648
-94
-0.9% -$10.7K 0.02% 474
2019
Q4 		$1.39M Buy
+10,742
New +$1.08M 0.01% 527

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

DnB Asset Management's SRPT Position: Q2 2025 in Review

DnB Asset Management sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 9,048 shares — an estimated $577K sold.

DnB Asset Management first reported a position in SRPT in Q4 2019 and held it in 12 quarters. The position peaked at $5.27M in Q4 2020. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • DnB Asset Management reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • DnB Asset Management sold 9,048 Sarepta Therapeutics shares in Q2 2025, an estimated $577K.
  • DnB Asset Management first reported a position in Sarepta Therapeutics in Q4 2019 and held it in 12 quarters.
  • DnB Asset Management's Sarepta Therapeutics position peaked at $5.27M in Q4 2020.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on DnB Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.